T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease

Abstract Introduction The reporting of approaches facilitating the most efficient and timely recruitment of Alzheimer's disease (AD) patients into pharmacologic trials is fundamental to much‐needed therapeutic progress. Methods T2 Protect AD (T2), a phase 2 randomized placebo‐controlled trial of tro...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Aladdin H. Shadyab, Andrea Z. LaCroix, Genevieve Matthews, Daniel Bennett, Alexandre A. Shadyab, Donna Tan, Ronald G. Thomas, Jennifer Mason, Alex Lopez, Brianna Askew, Lia Donahue, Stephen Kaplita, Irfan A. Qureshi, Branko Huisa, Howard H. Feldman, for the Alzheimer's Disease Cooperative Study T2 Protect AD Study Group
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2022-01-01
Schriftenreihe:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Schlagworte:	Alzheimer's disease clinical trial drug development pharmacologic recruitment
Online-Zugang:	https://doi.org/10.1002/trc2.12265
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!